Daniella Beckman
Chief Financial Officer; Director · 3 filings · Latest: Jun 11, 2026
Tango Therapeutics, Inc.
Upstream Bio, Inc.
Vor Biopharma Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
TNGX | DANIELLA BECKMAN | — | Jun 11, 2026 | Proposed Sale | $28.76 | 1,791,726 | $51.5M | — | |
TNGX | DANIELLA BECKMAN | — | Jun 10, 2026 | Proposed Sale | $30.00 | 4,446 | $133.4K | — | |
TNGX | Daniella Beckman | Chief Financial Officer | Feb 3, 2026 | Sale | $12.26 | 10,317 | $126.5K | 184,297 | |